224 related articles for article (PubMed ID: 12070869)
1. [Dopamine agonist is effective in Parkinson disease not only against tremor. Depression is also improved].
MMW Fortschr Med; 2002 May; Suppl 2():88. PubMed ID: 12070869
[No Abstract] [Full Text] [Related]
2. Pramipexole, a nonergot dopamine agonist, is effective against rest tremor in intermediate to advanced Parkinson's disease.
Künig G; Pogarell O; Möller JC; Delf M; Oertel WH
Clin Neuropharmacol; 1999; 22(5):301-5. PubMed ID: 10516884
[TBL] [Abstract][Full Text] [Related]
3. Pramipexole and ropinirole for Parkinson's disease.
Med Lett Drugs Ther; 1997 Nov; 39(1014):109-10. PubMed ID: 9398824
[No Abstract] [Full Text] [Related]
4. Pramipexole, ropinirole, and mania in Parkinson's disease.
Singh A; Althoff R; Martineau RJ; Jacobson J
Am J Psychiatry; 2005 Apr; 162(4):814-5. PubMed ID: 15800169
[No Abstract] [Full Text] [Related]
5. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG
Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211
[TBL] [Abstract][Full Text] [Related]
6. [Parkinson disease].
Moore AP; Clarke CE
Praxis (Bern 1994); 2001 Jun; 90(23):1041-6. PubMed ID: 11447724
[No Abstract] [Full Text] [Related]
7. Pramipexole in the treatment of Parkinson's disease: new developments.
Möller JC; Oertel WH
Expert Rev Neurother; 2005 Sep; 5(5):581-6. PubMed ID: 16162081
[TBL] [Abstract][Full Text] [Related]
8. [Pramipexole in Parkinson disease. Results of a treatment observation].
Reichmann H; Brecht HM; Kraus PH; Lemke MR
Nervenarzt; 2002 Aug; 73(8):745-50. PubMed ID: 12242961
[TBL] [Abstract][Full Text] [Related]
9. Alopecia induced by dopamine agonists.
Tabamo RE; Di Rocco A
Neurology; 2002 Mar; 58(5):829-30. PubMed ID: 11889256
[No Abstract] [Full Text] [Related]
10. New dopamine agonists on the horizon.
Heins JR
S D J Med; 1997 Jul; 50(7):239-40. PubMed ID: 9240032
[No Abstract] [Full Text] [Related]
11. Future therapies for Parkinson's disease.
Hauser RA; Lyons KE
Neurol Clin; 2004 Oct; 22(3 Suppl):S149-66. PubMed ID: 15501363
[No Abstract] [Full Text] [Related]
12. Parkinson's disease.
Clarke C; Moore AP
Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
[No Abstract] [Full Text] [Related]
13. [Treatment of later phases of Parkinson disease].
Tison F
Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F85-8. PubMed ID: 18680823
[No Abstract] [Full Text] [Related]
14. Slowing Parkinson's disease progression: recent dopamine agonist trials.
Montgomery EB
Neurology; 2004 Jan; 62(2):343; author reply 343-5. PubMed ID: 14745094
[No Abstract] [Full Text] [Related]
15. Pramipexole for Parkinson's disease.
Ting RM; Force RW
J Fam Pract; 1998 Jan; 46(1):19-20. PubMed ID: 9451363
[No Abstract] [Full Text] [Related]
16. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
Klos KJ; Bower JH; Josephs KA; Matsumoto JY; Ahlskog JE
Parkinsonism Relat Disord; 2005 Sep; 11(6):381-6. PubMed ID: 16109498
[TBL] [Abstract][Full Text] [Related]
17. Peripheral edema and dopamine agonists in Parkinson disease.
Tan EK
Arch Neurol; 2007 Oct; 64(10):1546-7; author reply 1547. PubMed ID: 17923645
[No Abstract] [Full Text] [Related]
18. [Dopamine agonist therapy in early Parkinson's disease. A survey of a Cochrane review].
Bode M
Ugeskr Laeger; 2009 Oct; 171(41):2996-9. PubMed ID: 19814927
[TBL] [Abstract][Full Text] [Related]
19. Dopamine agonists in early therapy for Parkinson disease: promise and problems.
Tanner CM
JAMA; 2000 Oct; 284(15):1971-3. PubMed ID: 11035895
[No Abstract] [Full Text] [Related]
20. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].
Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC
Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
